1. Home
  2. IRON vs RXRX Comparison

IRON vs RXRX Comparison

Compare IRON & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRON
  • RXRX
  • Stock Information
  • Founded
  • IRON 2017
  • RXRX 2013
  • Country
  • IRON United States
  • RXRX United States
  • Employees
  • IRON N/A
  • RXRX N/A
  • Industry
  • IRON Biotechnology: Pharmaceutical Preparations
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRON Health Care
  • RXRX Health Care
  • Exchange
  • IRON Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • IRON 2.0B
  • RXRX 2.4B
  • IPO Year
  • IRON N/A
  • RXRX 2021
  • Fundamental
  • Price
  • IRON $59.82
  • RXRX $4.83
  • Analyst Decision
  • IRON Strong Buy
  • RXRX Buy
  • Analyst Count
  • IRON 10
  • RXRX 4
  • Target Price
  • IRON $97.80
  • RXRX $7.25
  • AVG Volume (30 Days)
  • IRON 301.7K
  • RXRX 16.1M
  • Earning Date
  • IRON 11-11-2025
  • RXRX 11-05-2025
  • Dividend Yield
  • IRON N/A
  • RXRX N/A
  • EPS Growth
  • IRON N/A
  • RXRX N/A
  • EPS
  • IRON N/A
  • RXRX N/A
  • Revenue
  • IRON N/A
  • RXRX $64,596,000.00
  • Revenue This Year
  • IRON N/A
  • RXRX $24.09
  • Revenue Next Year
  • IRON N/A
  • RXRX $20.99
  • P/E Ratio
  • IRON N/A
  • RXRX N/A
  • Revenue Growth
  • IRON N/A
  • RXRX 30.14
  • 52 Week Low
  • IRON $30.82
  • RXRX $3.79
  • 52 Week High
  • IRON $68.73
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • IRON 50.30
  • RXRX 45.88
  • Support Level
  • IRON $58.59
  • RXRX $4.51
  • Resistance Level
  • IRON $61.27
  • RXRX $5.05
  • Average True Range (ATR)
  • IRON 2.13
  • RXRX 0.22
  • MACD
  • IRON -0.15
  • RXRX 0.03
  • Stochastic Oscillator
  • IRON 18.47
  • RXRX 63.33

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: